Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

403 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.
Tefferi A, Lasho TL, Patnaik MM, Finke CM, Hussein K, Hogan WJ, Elliott MA, Litzow MR, Hanson CA, Pardanani A. Tefferi A, et al. Among authors: hussein k. Leukemia. 2010 Jan;24(1):105-9. doi: 10.1038/leu.2009.225. Epub 2009 Oct 22. Leukemia. 2010. PMID: 19847199
MPLW515L mutation in acute megakaryoblastic leukaemia.
Hussein K, Bock O, Theophile K, Schulz-Bischof K, Porwit A, Schlue J, Jonigk D, Kreipe H. Hussein K, et al. Leukemia. 2009 May;23(5):852-5. doi: 10.1038/leu.2008.371. Epub 2009 Feb 5. Leukemia. 2009. PMID: 19194467
5-Azacitidine has limited therapeutic activity in myelofibrosis.
Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A. Mesa RA, et al. Among authors: hussein k. Leukemia. 2009 Jan;23(1):180-2. doi: 10.1038/leu.2008.136. Epub 2008 May 29. Leukemia. 2009. PMID: 18509350 Clinical Trial. No abstract available.
Bortezomib therapy in myelofibrosis: a phase II clinical trial.
Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A. Mesa RA, et al. Among authors: hussein k. Leukemia. 2008 Aug;22(8):1636-8. doi: 10.1038/leu.2008.32. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305559 Free PMC article. Clinical Trial. No abstract available.
403 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page